Literature DB >> 9357659

Telematics in the neonatal ICU and beyond: improving care for high-risk newborns and their families.

J Gray1, P C Jones, M Phillips, P Gertman, D Veroff, C Safran.   

Abstract

The Beth Israel-Deaconess has recently been awarded one of 19 contracts from the National Library of Medicine (NLM) to develop, implement and test a telemedicine application to support the care of Very Low Birth Weight Infants. This project is the only one to focus on the care of newborns. We believe that this project will provide a new national approach to managing the care of high-risk newborns by leveraging evolving communication technology.

Entities:  

Mesh:

Year:  1997        PMID: 9357659      PMCID: PMC2233440     

Source DB:  PubMed          Journal:  Proc AMIA Annu Fall Symp        ISSN: 1091-8280


  4 in total

1.  ComputerLink: electronic support for the home caregiver.

Authors:  P F Brennan; S M Moore; K A Smyth
Journal:  ANS Adv Nurs Sci       Date:  1991-06       Impact factor: 1.824

2.  Normal birth weight intensive care unit survivors: outcome assessment.

Authors:  J E Gray; M C McCormick; D K Richardson; S Ringer
Journal:  Pediatrics       Date:  1996-06       Impact factor: 7.124

3.  Using patient reports to measure health care system performance.

Authors:  J L Hargraves; R H Palmer; J Zapka; D Nerenz; H Frazier; E J Orav; C Warner; J Ingard; R Neisuler
Journal:  Clin Perform Qual Health Care       Date:  1993 Oct-Dec

Review 4.  Has the prevalence of handicapped infants increased with improved survival of the very low birth weight infant?

Authors:  M C McCormick
Journal:  Clin Perinatol       Date:  1993-03       Impact factor: 3.430

  4 in total
  1 in total

1.  Evaluation of Neonatal Services Provided in a Level II NICU Utilizing Hybrid Telemedicine: A Prospective Study.

Authors:  Abhishek Makkar; Mike McCoy; Gene Hallford; Arlen Foulks; Michael Anderson; Jennifer Milam; Marla Wehrer; Erica Doerfler; Edgardo Szyld
Journal:  Telemed J E Health       Date:  2019-11-01       Impact factor: 3.536

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.